QSIAW vs. RXRX

In the year-to-date period, QSIAW achieves a -37.60% return, which is significantly lower than RXRX's -32.69% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Quantum-Si incorporated (QSIAW) and Recursion Pharmaceuticals, Inc. (RXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current QSIAW Sharpe Ratio is 1.22, which is higher than the RXRX Sharpe Ratio of -0.58. The chart below compares the historical Sharpe Ratios of QSIAW and RXRX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither QSIAW nor RXRX has paid dividends to shareholders.

The maximum QSIAW drawdown since its inception was -98.83%, which is greater than RXRX's maximum drawdown of -90.39%. Use the drawdown chart below to compare losses from any high point for QSIAW and RXRX. For additional features, visit the drawdowns tool.

Quantum-Si incorporated (QSIAW) has a higher volatility of 70.84% compared to Recursion Pharmaceuticals, Inc. (RXRX) at 27.21%. This indicates that QSIAW's price experiences larger fluctuations and is considered to be riskier than RXRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Quantum-Si incorporated and Recursion Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.